US › Healthcare

Cumberland Pharmaceuticals Inc (CPIX)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$7.18-4.77%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$166,458

Revenue YoY

-98.5%

Net profit

$-4.1M

EPS

$-0.20

Net margin

-2,472.5%

Key statistics

Market cap

$112.2M

Forward P/E

50.0

P/B

6.05

Book value

$1.16

EPS (TTM)

$-0.67

52-week high

$9.28

52-week low

$1.13

50-day MA

$7.43

200-day MA

$5.40

Beta

0.04

Analyst view

with an average price target of $8.50.

Shareholding

Insiders

41.60%

Institutions

16.56%

Largest institutional holders

Fund	Stake
Ikarian Capital, LLC	3.36%
Renaissance Technologies Corp	3.19%
Vanguard Capital Management, LLC	2.53%
Dimensional Fund Advisors, Inc.	1.56%
BOOTHBAY FUND MANAGEMENT, LLC	0.75%
Geode Capital Management, LLC	0.72%
Perceptive Advisors LLC	0.65%
Citadel Advisors Llc	0.49%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Cumberland Pharmaceuticals Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.